ALS Ltd.

ALS Ltd.

15.50
USD
-0.27
(-1.74%)
0.44EPS
30.86P/E
7.11BMarket Cap
Nov 23Next Earn
ALS Ltd.
OTC:CPBLF
(OTC Markets)

Recent

price

15.50

P/E

ratio

30.86

div

yld

1.78%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
AUD
3.16
3.87
3.95
3.74
3.33
2.98
2.52
2.89
3.42
3.79
3.65
4.37
4.71
5.08
6.19
6.85
Revenue per Share
0.38
0.61
0.62
0.38
-0.41
-0.53
0.16
0.1
0.32
0.26
0.36
0.39
0.6
0.03
0.53
0.66
Basic EPS, GAAP
0.25
0.4
0.36
0.38
0.32
0.21
0.23
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.13
0.32
0.28
0.25
0.18
0.16
0.12
0.16
0.2
0.23
0.15
0.27
0.37
0.39
0.37
0.4
Dividend per Share
2.27
2.54
2.66
3.36
2.81
2.22
2.33
2.27
2.25
2.28
2.22
2.03
2.82
2.44
2.64
3.35
Book Value per Share
0.88
0.43
0.49
-0.01
-0.08
0.39
0.38
0.26
0.1
-0.13
-0.14
-0.44
-0.1
-0.67
-0.84
0.18
Tangible Book Value per Share
351
364
368
402
427
458
504
501
487
483
482
482
484
484
484
485
Basic Weighted Avg Shares
1,108
1,406
1,456
1,503
1,422
1,365
1,272
1,447
1,665
1,832
1,761
2,109
2,279
2,462
2,999
3,320
Sales/Revenue/Turnover
16.62
23.08
23.56
15.81
13.84
10.7
13.29
14.32
15.46
15.13
15.12
15.1
18.95
16.32
14.15
15.91
Operating Margin (%)
42
46
55
83
96
102
69
71
75
133
133
139
152
174
234
253
Depreciation Expense
132
222
227
154
-174
-241
82
52
154
128
173
191
291
13
256
319
Net Income, GAAP
28.54
27.98
28.47
27.4
- -
- -
29.4
41.59
27.1
48.38
29.94
31.94
29.28
87.63
28.62
29.27
Effective Tax Rate (%)
11.94
15.82
15.62
10.27
-12.27
-17.63
6.41
3.58
9.24
6.98
9.8
9.03
12.78
0.52
8.54
9.6
Profit Margin (%)
170
310
305
252
397
500
473
386
64
350
233
-639
141
177
392
314
Working Capital
153
499
522
750
935
749
701
696
514
1,569
927
1,269
1,269
1,554
1,929
1,455
LT Debt
826
930
997
1,419
1,228
1,128
1,185
1,122
1,103
1,111
1,080
994
1,378
1,197
1,294
1,705
Total Equity
13.38
18.69
15.57
8.98
- -
- -
6.28
4.48
10.06
3.9
7.27
8.43
10.55
1.65
9.64
10.99
Return on Invested Capital (%)
15.07
18.91
16.17
9.09
- -
- -
5.37
3.61
9.59
5.97
7.81
8.54
11.18
0.61
9.6
10.79
Return on Capital (%)
18.23
25.44
23.8
12.9
-13.3
-20.62
7.11
4.53
13.96
11.65
15.91
18.57
24.79
1.01
20.8
21.39
Return on Common Equity (%)

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.34%
11.49%
31.75%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
192.27%
375.62%
24.4%
Sales/Revenue/Turnover
9.65%
13.67%
10.69%
Total Cash Common Dividend
14.79%
25.75%
9.32%

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2,462
2025
- -
- -
2,999
2026
- -
- -
3,320

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.03
2025
- -
- -
0.53
2026
- -
- -
0.66

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.39
2025
- -
- -
0.37
2026
- -
- -
0.4
Business
ALS Limited (ASX:ALQ) provides professional technical services, primarily testing, measurement, and inspection solutions to the mining, environmental, life sciences, energy, and industrial sectors worldwide. The company operates through three main divisions: Commodities, offering geochemistry, metallurgy, coal testing, mine site services, and inspection for the global mining industry; Life Sciences, delivering environmental monitoring, food and pharmaceutical quality assurance, electronics testing, animal health, and consumer products analysis; and Industrial, providing asset care, tribology, diagnostic testing, and engineering services for energy, resources, transportation, and infrastructure. ALS maintains approximately 350 laboratory and operational sites across Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States, serving diverse clients including mining companies, pharmaceutical firms, food producers, and industrial operators. Founded as Australian Laboratory Services in 1974 and acquired in 1981 by Campbell Brothers (now ALS Limited, listed on the ASX since 1952), the company is headquartered in Brisbane, Australia. In 2024, ALS completed the acquisition of Europe-based Wessling Holding GmbH & Co. KG, adding around 1,200 employees and expanding its Life Sciences footprint, particularly in environmental, food, and pharmaceutical testing markets in Germany and France; it also acquired Northeast USA-based York Analytical Laboratories to bolster its North American operations.

Company News

  • ALS Limited (CPBLF) Shareholder/Analyst Call Transcript

  • ALS Limited (CPBLF) Q4 2026 Earnings Call Transcript

  • ALS (OTCMKTS:CPBLF) & Ipsos (OTCMKTS:IPSOF) Financial Survey

  • ALS Ltd delivers $3 billion revenue in FY25, unveils $350 million equity raise